ReviewProteomics2025
Applicability Assessment of Technologies for Predictive and Prescriptive Analytics of Nephrology Big Data.
Review in Proteomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The integration of big data into nephrology research will open new avenues for analyzing and understanding complex biological datasets, driving advances in personalized management of kidney diseases. This paper describes the multifaceted challenges and opportunities by incorporating big data in nephrology, emphasizing the importance of data standardization, advanced storage solutions, and advanced analytical methods. We discuss the role of data science workflows, including data collection, preprocessing, integration, and analysis, in facilitating comprehensive insights into disease mechanisms and patient outcomes. Furthermore, we highlight predictive and prescriptive analytics, as well as the application of large language models (LLMs) in improving clinical decision-making and enhancing the accuracy of disease predictions. The use of high-performance computing (HPC) is also examined, showcasing its role in processing large-scale datasets and accelerating machine learning algorithms. Through this exploration, we aim to provide a comprehensive overview of the current state and future directions of big data analytics in nephrology, with a focus on enhancing patient care and advancing medical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.